NCT06211231

Brief Summary

The purpose of the study is to assess the effect of a digital mindfulness- and acceptance-based psychological intervention on quality of life, work ability, pain experience and physical and mental health in participants experiencing chronic pain, fatigue and/or reduced quality of life due to endometriosis.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
255

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started Feb 2024

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Feb 2024Dec 2026

First Submitted

Initial submission to the registry

January 8, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 18, 2024

Completed
20 days until next milestone

Study Start

First participant enrolled

February 7, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

April 3, 2024

Status Verified

April 1, 2024

Enrollment Period

1.9 years

First QC Date

January 8, 2024

Last Update Submit

April 2, 2024

Conditions

Keywords

EndometriosisQuality of lifeDigital psychological interventionsRandomized controlled trialMindfulness-based interventionAcceptance and commitment therapyPelvic pain

Outcome Measures

Primary Outcomes (1)

  • Quality of Life (QoL)

    QoL is measured using the Endometriosis Health Profile-30 scale, on a scale from 0 to 100, with higher scores indicating worse quality of life.

    Change in Endometriosis Health Profile-30 from pre-randomization to after sessions 5 and 10, and 3, 6 and 12 months post-randomization. Primary outcome comparison is between baseline and post-intervention (after session 10.)

Secondary Outcomes (13)

  • Quality of Life subdomains

    Change in Quality of Life subdomains from pre-randomization to after sessions 5 and 10, and 3, 6 and 12 months post-randomization.

  • Work ability

    Change in Work Ability Index from pre-randomization to after sessions 5 and 10, and 3, 6 and 12 months post-randomization.

  • Pain and other endometriosis symptoms

    Change in pain and other endometriosis symptoms from pre-randomization to after sessions 5 and 10, and 3, 6 and 12 months post-randomization.

  • Pain acceptance

    Change in Chronic Pain Acceptance Questionnaire from pre-randomization to after sessions 5 and 10, and 3, 6 and 12 months post-randomization.

  • Sleep quality

    Change in Pittsburgh Sleep Quality Index from pre-randomization to after sessions 5 and 10, and 3, 6 and 12 months post-randomization.

  • +8 more secondary outcomes

Study Arms (3)

Self-guided digital intervention

EXPERIMENTAL

The program consists of 10 online sessions that teach and guide different endometriosis-related themes. The sessions include mindfulness-meditation, yoga, written assignments and patient-education, that are accessed through the digital platform. Participants continue medical treatment as usual.

Behavioral: Digitally delivered mindfulness- and acceptance-based psychological intervention

Therapist-guided digital intervention

EXPERIMENTAL

The program consists of 10 online sessions that teach and guide different endometriosis-related themes. The sessions include mindfulness-meditation, yoga, written assignments and patient-education, that are accessed through the digital platform. This arm includes 11 online video-consultations with a therapist (one prior to starting and one for each session.) Participants continue medical treatment as usual.

Behavioral: Digitally delivered mindfulness- and acceptance-based psychological intervention

No-treatment control group (waiting list)

NO INTERVENTION

Participants randomized to the waiting list will be offered one of the two experimental treatments. Participants continue medical treatment as usual.

Interventions

MY-ENDO is developed specifically for endometriosis and includes ten themes; one for each session: 1) endometriosis, 2) chronic pain and pain mechanisms, 3) stress, 4) thoughts and feelings, 5) grief, 6) identity and meaning, 7) everyday life and relations, 8) health, diet and exercise, 9) value-based action and 10) a good life with endometriosis.

Self-guided digital interventionTherapist-guided digital intervention

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥18 years old.
  • Signed informed consent.
  • Endometriosis diagnosed by a gynecologist based on the medical case history, ultrasound, laparoscopy, or MRI (all self-reported).
  • Moderate to severe symptoms (pelvic pain and/or fatigue measured on an 11-point numeric rating scale (NRS) from 0 = no pain/fatigue to 10 = worst imaginable pain/fatigue symptom) or reduced endometriosis-related quality of life (measured by the EHP-30):
  • Moderate to severe endometriosis-related chronic pelvic pain (NRS \> 2) or
  • Moderate to severe endometriosis-related fatigue (NRS \> 2) or
  • Low endometriosis-related quality of life (one or more EHP-30 subscale mean scores ≥ 40.00).
  • Relevant clinical and/or surgical treatment according to the European Society of Human Reproduction and Embryology (ESHRE) guidelines for endometriosis has been attempted.
  • Willingness to practice mindfulness and yoga at home for 30-45 minutes 5-7 days a week during the treatment period.

You may not qualify if:

  • Under 18 years old.
  • Severe psychiatric diagnosis made by a psychiatrist and/or ongoing psychiatric treatment.
  • Pregnancy or planned pregnancy during the study period.
  • An estimated lack of capacity or surplus energy to enter into a digital mindfulness treatment, for instance, because of:
  • major life events taking place at the same time (e.g., divorce, loss of a close relative, etc.)
  • linguistic or cultural barriers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Aarhus University Hospital, Department of Gynaecology and Obstetrics

Aarhus, Central Jutland, DK-8000, Denmark

RECRUITING

The Danish Endometriosis Patients Association

Billund, DK-7190, Denmark

RECRUITING

MeSH Terms

Conditions

EndometriosisPelvic Pain

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Henrik Marschall, MSc

    University of Aarhus

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Henrik Marschall, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Only principal investigator is blinded, as neither participants nor care providers can be feasibly blinded, since both parties will know if a video consultation is provided or not. The study includes only patient-reported outcomes, hence, the outcome assessors are the participants.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are randomized to one of three groups: 1) self-guided digital intervention, 2) therapist-guided digital intervention, or 3) no-treatment control group (waiting list)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 8, 2024

First Posted

January 18, 2024

Study Start

February 7, 2024

Primary Completion

December 31, 2025

Study Completion (Estimated)

December 31, 2026

Last Updated

April 3, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will share

When participant inclusion has ended, data can be shared in accordance with the International Committee of Medical Journal Editors (ICJME) guidelines, if relevant research objectives are provided. Data sharing will require approval from the Research Ethics Committee in Denmark and the Danish Data Protection Agency, and the requesting party shall cover any fees associated with data sharing. Requests for data can be addressed to hmars@psy.au.dk.

Locations